vktx stock price rally is partially driven by algorithmic buying programs triggered by positive momentum scores. Market depth data show strong bid support above $32.50, limiting downside risk. Investors should note that institutions actually own more than half the company, so they can collectively wield significant power. Viking Therapeutics is not owned by hedge funds. The company's largest shareholder is FMR LLC, with ownership of 10%. In comparison, the second and third largest shareholders hold about 9.1% and 5.3% of the stock. Furthermore, CEO Brian Lian is the owner of 1.7% of the company's shares. Viking Therapeutics, Inc. (VKTX) : Free Stock Analysis Report Weekly gains in vktx stock price have been fueled by speculative interest ahead of anticipated conference presentations. Pre-market trades suggest persistent demand even in low-liquidity phases.
